DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TYSABRI (natalizumab)
       *****************************************************
       #Post#: 3250--------------------------------------------------
       European Commission grants marketing authorization for subcutane
       ous Tysabri
       By: agate Date: April 8, 2021, 12:38 am
       ---------------------------------------------------------
       Tysabri may soon be available for subcutaneous administration,
       eliminating the need for trips to infusion centers, according to
       this article in StreetInsider (April 7, 2021):
  HTML https://bit.ly/3mthepc
       #Post#: 3281--------------------------------------------------
       FDA doesn't approve subcutaneous Tysabri
       By: agate Date: May 7, 2021, 1:04 am
       ---------------------------------------------------------
       Well, maybe not.
       This is from Biogen (April 28, 2021) and reports that the FDA
       has refused to approve its plan for subcutaneous administration
       of Tysabri:
  HTML https://bit.ly/3er1tNq
       *****************************************************